Chapter 4: Pharmacokinetics

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

So, imagine there's a hunter right deep in the South American rainforest.

He spots his prey, readies a blow dart tipped with this really lethal poison called curare and he takes a shot.

Right, which is highly effective.

Oh, incredibly effective.

The animal's instantly paralyzed, it drops to the ground and the hunter eventually, you know, takes it home, cooks it and eats the meat.

And he's perfectly fine.

Exactly.

He is totally fine.

But here's the million dollar question for you.

How can that hunter eat an animal killed by a potent paralytic poison and just go about his day?

But if say a single drop of that exact same poison were to accidentally get into a paper cut on his hand, he would be dead in minutes.

It is a wild paradox, but it actually makes perfect chemical sense once you understand the mechanics, which is exactly what we're getting into today.

Welcome to the deep dive.

We are the last minute lecture team and we are so glad you were here with us because today we are conquering chapter four from liens pharmacology nursing care and I promise you by the end of this conversation, that whole rainforest survival trick will make complete logical sense.

It really will because it all comes down to the underlying mechanics of how chemicals interact with the human body.

And before we get into the heavy science, there is a specific note in the reading, the note to chemophobes, which establishes a very reassuring ground rule for you.

Yes, I love that note.

Right.

If just hearing the word chemistry makes your heart race,

take a deep breath.

We are not going to be drawing like complex molecular structures or balancing equations today.

We are simply going to understand the journey of a drug.

Yeah, the literal journey.

Exactly.

In fact, pharmacokinetics literally translates to drug in motion.

It comes from the Greek word pharmacon, meaning drug or poison and kinesis meaning motion.

Drug in motion.

I mean, I really like that.

It feels so much less intimidating treating this like some massive dictionary of side effects that you just have to memorize.

It's totally different.

It's a process.

Yeah.

And to understand this motion, we are going to follow a really specific roadmap, which the book lays out beautifully in figure 4 .1.

It's built around the acronym ADME.

That stands for absorption, distribution, metabolism and excretion.

Right, ADME.

So a drug enters the body, that's absorption.

It moves into the bloodstream and gets sent out to the tissues.

That's distribution.

It's chemically broken down, which is metabolism and is finally kicked out excretion.

And you know, the ultimate therapeutic goal tying all four of those ADME processes together is actually very straightforward.

We are constantly trying to achieve the right concentration of a drug at its specific site of action.

The sweet spot.

Exactly.

The sweet spot.

We need the level high enough to maximize the therapeutic benefits, but we need it low enough to minimize harm and toxicity.

But before a drug can even start that ADME journey, before it can be absorbed or anything else, it faces this massive physical hurdle.

It has to cross the cell membrane.

That is the fundamental barrier.

I mean, every single biological process requires crossing membranes.

And if you look at figure 4 .2 in the text, you'll see they are primarily composed of a phospholipid bilayer.

Basically a fat sandwich.

Yeah, exactly.

A microscopic sandwich made of two layers of fats.

And because of this universal rule in chemistry that says like it dissolves like drugs that are lipid soluble, meaning they are lipophilic or fat loving, they can dissolve right into that fatty membrane.

They just slide right through.

Yep.

They cross over into the cell with virtually no resistance.

I always picture the cell membrane as the bouncer at like a really exclusive VIP club.

Lipid soluble drugs.

They're on the VIP list.

They don't even have to show ID.

They just walk right past the bouncer directly through the membrane itself.

That's a great way to think about it.

But water soluble drugs, you know, the polar molecules or ions which carry an electrical charge, the bouncer is definitely not letting them in.

No, those molecules are completely locked out unless they find an alternative entry point.

Sometimes that entry point is a tiny channel or pore, but those windows are so minuscule, they only accommodate the smallest of molecules like

sodium or potassium ions.

So what if the drug is big and not on the VIP list?

Well, if a drug is too big and isn't lipid soluble, it needs a dedicated transport system.

It's essentially a molecular escort that binds to the drug and physically carries it across the barrier.

Wait, if there are systems specifically designed to carry drugs into the cell, couldn't the body just use those to absorb literally everything?

You would think so, right.

But transport systems are highly selective.

They only carry very specific molecules.

And even more fascinating, transport systems do not just bring drugs in.

Many of them are actually designed to throw drugs out.

Throw them out.

Yeah.

There is a crucial multidrug transporter called P glycoprotein or PGP for short.

It is heavily concentrated in the liver, the kidneys, the placenta, the intestine, and the capillaries of the brain.

And its primary function is actually protective.

It pumps drugs out of cells.

Oh, so it's club security, physically tossing rowdy guests out the back door.

That is a perfect visualization.

In the brain, PGP pumps drugs back into the blood to prevent them from entering the central nervous system.

In the placenta, it constantly pumps drugs back into the maternal circulation to protect the developing fetus.

Which, okay, this brings us right back to our poisoned rainforest hunter.

The poison he used, curar, is a classic example of how a drug's chemical structure dictates its ability to cross these very membranes.

Exactly.

Curar is what chemists call a quaternary ammonium compound.

Because of its atypical nitrogen bonding, it always carries a positive electrical charge.

It is permanently an ion.

And like we said with the VIP list, ions simply cannot cross cell membranes.

Right.

They are actively repelled.

So when the hunter eats the meat, the curar goes into his stomach.

But because it has that permanent positive charge, it just bounces off the intestinal membrane.

It stays completely trapped inside the digestive tract and eventually just passes through harmlessly.

But if he gets it in a cut...

Or injects it into a vein...

Yeah, then it completely bypasses that membrane barrier.

Once it is directly in the bloodstream, it doesn't need to cross the digestive lining at all.

It travels straight to the muscles and the respiratory system, causing lethal paralysis.

That is so wild.

I mean, the exact same chemical is a totally harmless dietary additive in the stomach, but a lethal weapon in the blood.

All because of its electrical charge.

It's all about the charge.

But not every drug is permanently charged, like curare, right?

Like most of the medications you'll give as inerts aren't aeropoisons.

True.

Most drugs are actually weak organic acids or weak organic bases.

This means their electrical charge is not permanent.

They can exist in either a charged state or an uncharged state, entirely depending on the pH of the environment they're in.

Okay.

So they can flip back and forth.

Exactly.

The rule of thumb here, and you can see this mapped out in figure 4 .5, is that acids tend to ionize, meaning they take on an electrical charge in alkaline or basic environments.

Conversely, bases tend to ionize in acidic environments.

Okay.

Let me make sure I'm visualizing this correctly for you guys listening.

Aspirin is a weak acid.

When I swallow an aspirin, it lands in my stomach, which is essentially, well, a vat of highly concentrated acid.

Right.

Very acidic.

Because aspirin is an acid and it's sitting in an acidic environment, it does not ionize.

It stays uncharged.

Correct.

And because it remains uncharged and is lipid soluble, it easily crosses the stomach membrane and slips directly into the bloodstream.

Nice.

But the journey doesn't end there.

Blood is slightly alkaline compared to the stomach.

Ah.

So the environment just changed from acidic to basic.

It did.

And once that acidic aspirin molecule hits the alkaline blood, it gives up a proton and instantly becomes ionized.

It takes on an electrical charge.

And because ions can't cross membranes, it can't go back.

Exactly.

It is entirely trapped in the blood.

This phenomenon is known as pH partitioning or ion trapping.

A drug will always accumulate on the side of a membrane where the pH most heavily favors its ionization.

That concept of ion trapping is brilliant.

And we're going to look at a literal lifesaver of a clinical application for it in just a few minutes.

But let's follow our aspirin into the blood.

We have officially entered the A in ADME absorption.

Which is moving the drug from its site of administration into the bloodstream.

Right.

And obviously how we administer it changes the entire game.

Table 4 .1 in the text lays this out perfectly.

Yeah.

The route is everything.

We generally divide these into enteral routes, meaning anything passing through the GI tract, and parenteral routes, which technically means outside the GI tract.

But in clinical practice, it almost always refers to injection.

So let's start with IV.

Intravenous administration.

The barrier to absorption here is basically non -existent, right?

Yeah.

I mean, the drug goes straight into the vein.

It's instantaneous and 100 % complete.

Yeah.

Honestly, that sounds ideal.

Why don't nurses just give every single medication via IV and skip the unpredictable stomach altogether?

Because zero barriers also means you have zero safety net.

Oh, that's a good point.

The IV route is expensive.

It requires specialized training to establish a line.

But most critically for a nurse, it is absolutely irreversible.

Once you push that plunger, the drug is in the systemic circulation.

You cannot take it back.

You can't pump the patient's stomach.

Wow.

You're committed.

Fully committed.

Plus you face the very real physical dangers of fluid overload, serious infections, and embolisms if the drug hasn't fully dissolved.

And structurally, drugs given IV must be water soluble.

That irreversibility is terrifying when you think about the potential for human error, which actually leads right into a massive safety warning from the chapter regarding fairy bee administration, the 15 second rule.

Yes.

This is a metric every nursing student needs etched into their brain.

All the blood in the human body completes a full circulation roughly once every minute.

Okay.

But if you inject a drug into the anticubital vein in the arm, that drug will physically reach the brain in just 15 seconds.

13 seconds.

Yep.

If you push an IV medication too quickly and the dose happens to be excessive, central nervous system toxicity will hit the patient almost instantly.

So you basically have a 15 second window before a mistake becomes a total catastrophe.

Which is why the standard protocol is to inject most IV drugs slowly over a span of at least one full minute.

Pushing it slowly dilutes the medication within the largest volume of blood possible.

Crucially, it allows you to observe the patient.

And if signs of toxicity suddenly appear at that 15 second mark, you can immediately stop the injection before the rest of the dose is delivered.

That timing is so crucial.

But so is obsessively reading your labels, because a drug might say it is for injection, but that definitely does not mean it is for an IV.

The reading gives two incredibly jarring examples of this.

They are classic examples for a reason.

Right.

First is insulin.

Regular insulin is perfectly safe to give intravenously.

But NPH insulin contains particulate matter.

If you administer NPH intravenously, those particles can cause a fatal blockage.

And the second example is epinephrine.

Epinephrine is packaged in drastically different concentrations depending on how it is meant to be used.

A solution prepared for a subcutaneous injection is highly concentrated.

A solution meant for IV administration is very dilute.

If a nurse accidentally grabs that concentrated subq epinephrine and pushes it directly into a vein, the massive cardiovascular overstimulation could cause a fatal stroke right there on the spot.

Always, always check the formulation.

So IV is instantaneous but dangerous.

What about the other injections?

Intramuscular and subcutaneous.

The dynamics for IM and subq are very similar to each other.

The only barrier to absorption is the capillary wall itself.

And the spaces between the cells that make up a capillary wall are large enough that drugs pass through with very little resistance.

Okay.

So it's an easy trip.

Very easy.

These routes are excellent for drugs that are poorly soluble in water, and they provide the only mechanism for administering depot preparations.

Right.

A depot preparation is when the drug is suspended in a way that it releases slowly over time, right?

Yes.

For example, you can administer a single intramuscular injection of benzathine penicillin G, and because of how it is formulated, it will remain in the muscle and slowly release therapeutic amounts of the antibiotic into the blood for an entire month.

That is infinitely more convenient than trying to remember to take a pill every single day.

Which brings us to the oral or PO route.

And honestly, this seems like the Wild West compared to injections.

It kind of is.

When you swallow a pill, it has to survive the stomach, cross the GI epithelium, and the way the pill is manufactured totally changes how much of the drug actually makes it.

The variability is immense.

I mean, even with standard, seemingly identical tablets,

different pharmaceutical manufacturers use different proprietary binders and fillers.

That means two tablets containing the exact same dose of active medication can dissolve at completely different rates in the stomach, resulting in different bioavailabilities for the patient.

And then there is the whole world of enteric coated preparations.

These are fascinating to me because they're covered in a material, usually like a plant -based wax or shellac, specifically designed to withstand the highly acidic environment of the stomach.

Right.

They just pass right through.

Yeah.

They don't dissolve until they reach the alkaline environment of the small intestine.

Which serves two purposes.

It protects drugs that would be destroyed by stomach acid, and it protects the stomach lining from drugs that would cause severe gastric irritation.

But this introduces a major nursing hazard.

What happens if a patient has difficulty swallowing, so you crush their enteric coated pill and mix it in applesauce?

You completely destroy the protective wax coating.

So now either the drug hits the acid and is completely obliterated, meaning the patient gets zero therapeutic effect, or worse, you unleash a severe irritant directly onto their stomach lining, causing terrible pain and bleeding.

Exactly.

Never, ever crush an enteric coated pill.

It defeats the entire pharmaceutical design, and the same goes for sustained release capsules.

These are filled with tiny spheres that contain the drug, but the spheres have coatings that dissolve at different rates.

The goal is to release the medication steadily throughout the day.

So if you crush those.

Crushing them delivers a massive,

potentially toxic dose all at once.

All right.

So our drug has successfully navigated the stomach, crossed the membrane, and it absorbed.

It's in the blood.

Now we hit D, distribution.

We need to move the drug from the bloodstream out into the actual tissues where it's needed.

And the primary driving force for distribution is local blood flow.

Tissues that are highly perfused get the drug rapidly.

But this presents a unique challenge for two specific pathological conditions, abscesses and solid tumors.

Right.

An abscess is a localized pocket of infection filled with pus, and it lacks any internal blood vessels.

Meaning there's literally no physical highway for the antibiotic to get inside the infection.

Exactly.

The blood simply flows around it.

This is why an abscess typically has to be surgically drained before antibiotic therapy can be truly effective.

Solid tumors present a similar obstacle.

They have a blood supply on the outer edges, but the core of a solid tumor has very low blood flow, making it incredibly difficult to deliver high concentrations of chemotherapy deep into the center of the mass.

Assuming the tissue has normal blood flow, though, how does a drug physically exit the

membrane?

In a typical capillary bed, no.

And you can see this in Figures 4 .7, 4 .8, and 4 .9.

The architecture of a normal capillary is somewhat like a brick wall with very loose mortar.

There are relatively large gaps between the cells.

Drugs simply slip right through those gaps to exit the bloodstream.

Just slip right out.

Right.

But the central nervous system is built differently.

The blood -brain barrier features tight junctions.

The bricks are cemented flush against each other with zero gaps.

So the drug cannot slip between the cells.

It has to pass directly through the cells of the capillary wall to get into the brain.

Which means it must be highly lipid soluble, or it must have a specialized transport system.

The blood -brain barrier is a phenomenal defense mechanism against circulating toxins, but it makes treating central nervous system infections exceptionally frustrating.

And we also need to remember that this barrier is not fully developed at birth.

Oh, which explains why newborns are so profoundly sensitive to medications that affect the brain.

Their barrier hasn't fully sealed yet.

Exactly.

Now, speaking of vulnerable populations, let's talk about the placenta.

I feel like there is this huge misconception that the placenta is an impenetrable shield for the fetus.

It is an incredibly dangerous fallacy.

The placenta is absolutely not an absolute barrier.

It follows the exact same chemical rules as any other cell membrane.

Lipid soluble, non -ionized drugs, which includes things like maternal opioids or anesthetics, they readily dissolve right through the placental membrane and enter the fetal circulation.

Wow.

This is why administering certain pain medications during labor can lead to severe respiratory depression in the neonate upon delivery.

Okay, let's look at one of my absolute favorite visual analogies from the text, Figure Four Point Desia, which explains protein binding.

Imagine the protein albumin is this massive multi -level tour bus.

It is so physically large that it can never leave the highway of your bloodstream.

It is far too big to squeeze through those capillary gaps we just talked about.

And the drug molecules are the passengers.

Yes.

It perfectly illustrates the dynamic.

Drugs can bind reversibly to these albumin buses circulating in the plasma, but the strength of that attraction varies wildly from drug to drug.

Consider the anticoagulant warfarin.

It has an incredibly strong affinity for albumin.

At any given moment, about 99 % of the warfarin molecules in the blood will be bound to albumin.

They're stuck on the bus.

Stuck on the bus.

Only 1 % of the drug is free or unbound.

Hold on.

If albumin never leaves the bloodstream and the drug is stuck to it, doesn't that mean the drug is completely useless while it's on the bus?

Yes.

That is the crucial takeaway.

Only the free unbound drug molecules can exit the capillary and reach the site of action to exert an effect.

The bound drug is inactive.

So if 99 % of warfarin is stuck on the bus, and only 1 % is actually working, what happens if you introduce a second drug into the patient's system?

Well, the albumin bus has a strictly limited number of seats.

If you give a patient warfarin and then administer a second medication that also has a high affinity for albumin, the two drugs aggressively compete for those seats.

The new drug can literally kick warfarin molecules out of their seats.

Oh no.

So suddenly, that tiny 1 % of free active warfarin spikes to like 2 % or 3%.

That might sound like a small jump, but you just doubled or tripled the amount of active anticoagulant in the patient's body.

And suddenly your patient is at extreme risk for severe, spontaneous internal bleeding.

It is a game of molecular musical chairs that can be fatal if the nurse isn't monitoring for drug interactions.

Okay, so our drug has been absorbed, distributed, and done its job, but it can't stay in the body forever.

The body sees it as a foreign invader.

How does it start breaking it down?

We are moving to M, metabolism, or biotransformation.

The body's primary chemical laboratory is the liver, and the main engine of that lab is the cytochrome P450 enzyme system, which they map out in figure 4 .11.

Yeah, this P450 system isn't just one enzyme.

It's a massive group of enzyme families dedicated to chemically altering the structure of drugs.

And this liver laboratory produces six distinct therapeutic consequences.

First, and most importantly, it accelerates renal excretion.

Because the kidneys can't flush out highly lipid -soluble drugs, right?

I mean, if a drug is lepophilic, it just gets reabsorbed.

Precisely.

If the liver didn't step in, a highly lipid -soluble anesthetic like thiopental would take literally years to leave the body.

So the liver enzymes chemically alter these drugs, often through a process called glucuronidation, where they attach a hydrophilic or water -loving sugar molecule to the drug.

So it makes it water -soluble?

Instantly.

It makes the drug water -soluble so the kidneys can easily excrete it.

Okay, that's consequence one.

Consequence two is pretty straightforward.

The liver can simply inactivate drugs, dismantling them so they no longer work, like with the local anesthetic procaine.

But consequence three is where it gets kind of counterintuitive.

The liver can actually increase the therapeutic action of a drug.

The classic example is the pain medication codeine.

Codeine on its own is actually relatively work, but once it hits the liver lab, the P450 enzymes metabolize it directly into morphine.

Wow.

And that provides the profound pain relief

Consequence four is very similar.

Activating prodrugs.

A prodrug is basically a deactivated bomb.

When you administer a drug like phosphineutone, it does nothing.

It is entirely inactive until it passes through the liver, which chemically arms it, metabolizing it into the active drug phenytoin.

And finally, consequences five and six involve toxicity.

The liver can metabolize drugs to decrease their toxicity and making them safer.

But terrifyingly, it can also increase toxicity.

Right.

Like with Tylenol.

Exactly.

Acetaminophen is incredibly safe at normal doses.

But in an overdose situation, the standard metabolic pathways are overwhelmed and the liver begins metabolizing the acetaminophen into a highly hepatotoxic compound that destroys the liver itself.

Which highlights exactly why we have to be so careful with patients whose livers aren't functioning normally.

We already touched on infants.

You know, their liver enzyme systems aren't fully mature until they're about a year old, meaning they metabolize drugs very slowly and are at high risk for toxicity.

Right.

But we also have to watch out for drug interactions involving P450 inducers and inhibitors.

Inducers are drugs that essentially command the liver to manufacture more P450 enzymes.

They speed up the liver's metabolic engine.

If a patient starts taking an inducer, their liver begins breaking down other medications much faster.

As a nurse, you would likely need to increase the dosages of those other drugs just to maintain therapeutic levels.

And inhibitors do the exact opposite.

They throw a wrench into the P450 engine, slowing down metabolism, which causes other drugs to build up in the blood to potentially toxic levels.

Exactly.

But even with a perfectly healthy liver, there is a phenomenon called the first pass effect that completely alters how we administer certain drugs.

Nitroglycerin is the famous one here.

It is the ultimate example.

When a patient swallows a pill, it is absorbed from the GI tract and carried via the portal vein directly to the liver before it goes anywhere else in the body.

If the liver possesses an extremely high capacity to metabolize that specific drug, it will completely obliterate the drug on this very first pass.

The drug never even makes it to the systemic circulation.

So swallowing a nitroglycerin pill for chest pain is completely useless.

It undergoes rapid hepatic inactivation.

Which is why nitroglycerin must be administered sublingually, placed under the tongue.

The tissue under the tongue absorbs the drug directly into the systemic circulation, completely bypassing that initial trip to the liver.

But the liver has one more trick up its sleeve to keep drugs in the body,

enterohepatic recirculation, mapped out in Figure 4 .6.

Remember glucuronidation.

The liver makes a drug water -soluble and dumps it into the bile to be excreted.

The bile travels into the intestine.

You would assume it just gets flushed out in the stool.

But sometimes enzymes in the intestine hydrolyze the drug, cleaving off that water -soluble sugar molecule.

But the drug is lipid -soluble again.

Yes.

And because it is lipid -soluble again, it just absorbs straight back through the intestinal wall into the portal blood and goes right back to the liver.

Oh wow.

It creates a continuous loop, keeping the drug trapped in the body significantly longer than it otherwise would be.

It's incredible how the body recycles things.

But eventually, the drug has to leave.

The final step of our ADME journey is excretion, getting it out, primarily through the kidneys.

Right.

And Figure 4 .12 shows us renal excretion is a three -step process.

Step one is glomerular filtration.

As blood flows into the kidneys, it passes through the glomerular capillaries, which act like a massive filter paper.

Small molecules are forced out of the blood and into the urine.

But large molecules, like our albumin bus and any protein -bound drug stuck to it, they're too big for the filter.

They stay in the blood.

Step two is passive tubular reabsorption.

And this relies on everything we learned about membranes.

Because lipid -soluble drugs cross membranes easily, as the urine flows through the kidney tubules, those lipid -soluble drugs just sneak right back through the membrane into the bloodstream.

Which perfectly explains why the liver had to work so hard to make them water -soluble in the first place.

If they're water -soluble, or if they're ionized, they're physically incapable of crossing back into the blood.

They remain trapped in the urine.

And then the last step.

Finally, step three is active tubular secretion.

The kidneys have molecular pumps that actively push organic acids and bases out of the blood and into the urine, ensuring even more of the ion trapping.

Here's where that chemistry pays off with a brilliant clinical hack from the reading.

It explains how to treat a childhood aspirin overdose using nothing but pH manipulation.

It is applied pharmacokinetics at its finest.

Aspirin is a weak acid.

We establish that acids ionize in alkaline environments.

So if a child comes into the ER having overdosed on aspirin, the medical team will administer an agent that deliberately makes the child's urine alkaline.

So as the aspirin flows through the kidney and enters that alkaline urine, it instantly ionizes.

It takes on a charge.

And because ions cannot passively reabsorb back across the tubular membrane into the blood, the toxic aspirin is permanently trapped in the urine.

It is rapidly flushed safely away.

That is so smart.

And we can also manipulate excretion by creating competition for those active tubular pumps, right?

If you administer penicillin, those active pumps usually clear out of the blood extremely fast.

But if you administer a drug called probenicide at the exact same time, the probenicide occupies all the active pump.

It takes up all the space.

Yeah.

Penicillin literally has to wait in line in the blood, delaying its excretion and prolonging its antibacterial effects.

It's a great strategy.

But before we leave excretion, we must highlight that the kidneys aren't the only exit route.

Lipid soluble drugs can easily cross the cellular barriers of the mammary glands and be excreted in breast milk.

This poses a major direct risk to nursing infants.

If a patient is breastfeeding, they must consult the prescriber about every single medication or supplement they take.

All right.

So we know how the drug moves.

Now we have to understand the timeline.

How do nurses use blood levels to safely time their doses?

It all revolves around the therapeutic range, which is figure 4 .13.

At the very bottom of this range, you have the minimum effective concentration or MEC.

If plasma drug levels fall below the MEC, the drug does absolutely nothing.

At the top of the range, you have the toxic concentration.

The sweet spot sitting between those two markers is the therapeutic range.

If a drug has a wide therapeutic range, like acetaminophen, it's very safe.

The toxic level is roughly 30 times higher than the MEC.

You have a lot of room for error.

But lithium, which is used for bipolar disorder, has a terrifyingly narrow therapeutic range.

Very narrow.

The toxic level is only three times higher than the MEC.

A drug with a narrow range requires intense constant nursing monitoring because a minor dosing error could literally be fatal.

Which brings us to the most critical mathematical concept a nurse will use, drug half -life.

The half -life is simply the amount of time it takes for the total amount of drug in the body to decrease by exactly 50 percent.

So it drops by a percentage, not a specific milligram amount.

If morphine has a half -life of three hours and you have 50 milligrams in your body, three hours later you have 25 milligrams.

Another three hours past, you have 12 .5.

Wait, if it cuts in half every single time, doesn't it just get infinitely smaller and never actually hit zero?

Mathematically, yes, it gets infinitely smaller.

But practically, once it drops below a certain point, it is considered cleared.

But the true power of the half -life is how it dictates dosing.

When a patient takes repeated doses of a medication, the drug accumulates in the body until it reaches a steady plateau in the blood, which you can see in figure 4 .42.

The amount of drug being eliminated between doses perfectly matches the amount being administered in the next dose.

Think of it like pouring water into a bucket that has a small hole in the bottom.

Eventually, the water level stays steady.

And the rule for reaching that steady plateau is fascinating.

No matter what the dose size is, it always takes exactly four half -lives to reach that plateau.

Always four half -lives.

If a drug has a half -life of 24 hours, it will take four full days of repeated dosing to reach a steady therapeutic plateau.

But hold on.

If a patient is having a massive cardiac event, or they are screaming in severe pain, they need relief right this second.

We cannot tell them to wait four days for their medication to reach a therapeutic plateau.

We absolutely cannot.

And this is exactly why we utilize loading doses versus maintenance doses.

To bypass that four -day wait, we administer a massive loading dose up front.

This instantly spikes the plasma drug level to match what the therapeutic level.

We switch to much smaller maintenance doses simply to keep the level steady.

That makes perfect sense.

You fill the bucket immediately and then just pour in enough to match what's leaking out.

And let me guess the four half -life rule applies in reverse too.

It does.

Once you completely stop giving a medication, it takes exactly four half -lives for 94 % of that drug to clear the body.

This is why managing drug toxicity can become a literal nightmare for a nursing staff.

Because the reading mentions an older heart failure medication called

Digitoxin.

It has a half -life of seven days.

Think about the math on that.

If a patient accidentally becomes toxic on Digitoxin, it will take four half -lives, which is 28 full days for the drug to drop to a safe level.

Oh my gosh.

You are fighting to manage toxicity and keep that patient alive for nearly a month while the drug agonizingly slowly clears their system.

This is precisely why Digitoxin was largely abandoned and replaced by Dagoxin, a drug with the exact same therapeutic actions, but a significantly shorter half -life.

Man, we have tracked the drug from the moment it entered the body, watched it cross membranes, get distributed by the albumin bus, metabolized by the liver lab, and fleshed out by the kidneys.

You are officially ready to crush this material.

But before you close your notes, I want to leave you with one final provocative thought.

What's that?

We just learned that almost every single drug follows this strict, predictable mathematical rule of half -lives, dropping by 50 percent over a set period.

But there is one major everyday exception that we will actually encounter in a future chapter.

Ethanol.

Alcohol.

Oh yes.

It is the ultimate rule breaker.

It does not follow the half -life rule at all.

It leaves the body at a constant, fixed rate, regardless of how much alcohol is present in the blood.

Which is so strange.

It really is.

It completely throws a wrench in the standard pharmacokinetic models we just discussed.

Best of luck on the pharmacology exam.

You've totally got this.

On behalf of the Last Minute Lecture Team, thanks for joining us on this deep dive.

Take a breath, trust your studying, and we will see you next time.